Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Humana (HUM) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareHUM

Closing price · Nov 19, 2026 $380.12 -1.5% on the day · +67.9% over 12 months 52-week range $162.46 – $461.25
Get HUM alerts
Open-market purchases1 insider$150K · last 12 months
Insiders selling2last 12 months
Reported sales$2.6M0 of 2 recent sales pre-planned (10b5-1)
In 15 seconds

Some insider buying ($150K), but sales were much larger ($2.6M) over the same 12 months.

Past insider buys here: 1 of 1 beat the S&P 500 over the next 90 days (small sample). See each one ↓

Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Feb 12, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Joseph C. Ventura, General Counsel sold 5,495 shares at $433.85 ($2.4M).

Trade date
Nov 9, 2026
Disclosed to the SEC
Nov 12, 2026
Type
Sale (code S)

Read the original SEC filing ↗All HUM insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

HUM insider transactions (Form 4)

Open-market purchases and sales. 63 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Nov 12SEC Joseph C. VenturaGeneral Counsel Sell 5,49521,910 held (−20%) $433.85 $2.4M -12.4% —
Nov 12SEC Wayne A.I. FrederickDirector Sell 440 $440.57 $194K -13.7% —
Feb 25SEC Sanjay K. ShettyPresidentFirst buy Buy 81011,657 held (+7%) $185.21 $150K +105.2% —
Historical context

Similar past setups: not applicable. There aren't enough comparable past cases for HUM's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with HUM in the Research Lab

Pre-set to HUM's latest insider buy of $10K or more (Feb 25, 2026: Sanjay K. Shetty, $150K). Tap to change anything.

All tools →

Share price and insider trades

HUM closeInsider buyInsider sale
100200300400500DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-11EEarnings release filed 2026-04-29EEarnings release filed 2026-07-29EEarnings release filed 2026-11-06Bought $150,016 on 2026-02-23 · Sanjay K. ShettySold $193,853 on 2026-11-10 · Wayne A.I. FrederickSold $2,384,013 on 2026-11-09 · Joseph C. Ventura
Bought, 12 months$150K
Sold, 12 months$2.6M
Insiders buying1
Insiders selling2

Humana insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $150K and 2 sold $2.6M of HUM stock on the open market; P/E 39.8 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

HUM insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $150K bought (1 trades)$150KQ1 2026Q2 2026Q3 2026Q4 2026: $2.6M sold (2 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$2.6M2
Q3 2026—0—0
Q2 2026—0—0
Q1 2026$150K1—0

Valuation, profit and volume

P/E (trailing)39.8Sector median 25.0
Volume vs. 50-day1.4×Last 5 sessions
Insiders' paper profit+$158KOn all tracked purchases +105.2%

Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 1 Humana insider reported open-market purchases totaling $150K, while 2 insiders reported sales totaling $2.6M. 0 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

HUM earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Nov 6, 2026 -3.0% None +2.8%S&P +2.7% pending
Jul 29, 2026 -4.3% None -5.7%S&P +0.1% +5.1%
Apr 29, 2026 +15.9% None +2.9%S&P +1.0% +29.2%
Feb 11, 2026 -31.2% None -1.4%S&P -1.6% -7.5%
Nov 5, 2025 -0.7% None -10.9%S&P -0.7% +2.7%
Jul 30, 2025 +2.3% None +7.4%S&P -0.5% +21.5%
Apr 30, 2025 -8.9% None -1.3%S&P +0.7% -8.9%
Feb 11, 2025 -9.4% None -2.5%S&P -0.2% -2.7%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

HUM short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 57% of volume sold short2026-08-27: 53% of volume sold short2026-08-28: 63% of volume sold short2026-08-31: 54% of volume sold short2026-09-01: 56% of volume sold short2026-09-02: 54% of volume sold short2026-09-03: 50% of volume sold short2026-09-04: 45% of volume sold short2026-09-08: 67% of volume sold short2026-09-09: 63% of volume sold short2026-09-10: 45% of volume sold short2026-09-11: 53% of volume sold short2026-09-14: 56% of volume sold short2026-09-15: 45% of volume sold short2026-09-16: 44% of volume sold short2026-09-17: 34% of volume sold short2026-09-18: 49% of volume sold short2026-09-21: 44% of volume sold short2026-09-22: 40% of volume sold short2026-09-23: 40% of volume sold short2026-09-24: 41% of volume sold short2026-09-25: 48% of volume sold short2026-09-28: 51% of volume sold short2026-09-29: 54% of volume sold short2026-09-30: 57% of volume sold short2026-10-01: 56% of volume sold short2026-10-02: 63% of volume sold short2026-10-05: 61% of volume sold short2026-10-06: 69% of volume sold short2026-10-07: 53% of volume sold short2026-10-08: 45% of volume sold short2026-10-09: 48% of volume sold short2026-10-12: 45% of volume sold short2026-10-13: 53% of volume sold short2026-10-14: 54% of volume sold short2026-10-15: 52% of volume sold short2026-10-16: 58% of volume sold short2026-10-19: 72% of volume sold short2026-10-20: 61% of volume sold short2026-10-21: 36% of volume sold short2026-10-22: 55% of volume sold short2026-10-23: 36% of volume sold short2026-10-26: 32% of volume sold short2026-10-27: 61% of volume sold short2026-10-28: 39% of volume sold short2026-10-29: 33% of volume sold short2026-10-30: 41% of volume sold short2026-11-02: 44% of volume sold short2026-11-03: 35% of volume sold short2026-11-04: 37% of volume sold short2026-11-05: 43% of volume sold short2026-11-06: 29% of volume sold short2026-11-09: 20% of volume sold short2026-11-10: 20% of volume sold short2026-11-11: 22% of volume sold short2026-11-12: 32% of volume sold short2026-11-13: 43% of volume sold short2026-11-16: 42% of volume sold short2026-11-17: 39% of volume sold short2026-11-18: 31% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 31%20-day average: 34%Prior 2 months: 52%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded HUM

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +125.3%

What happened after HUM insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
Feb 25, 2026Sanjay K. ShettyPresident$150K +4.0%+5.2% vs S&P-3.5%+4.8% vs S&P+72.2%+63.6% vs S&P

Insiders at Humana

InsiderBoughtSoldLast filingPast buys beat S&PScore
Joseph C. VenturaGeneral Counsel — $2.4M Nov 12, 2026 — —
Sanjay K. ShettyPresident $150K — May 5, 2026 — —
Wayne A.I. FrederickDirector — $194K Nov 12, 2026 — —
David DintenfassPresident — — Nov 12, 2026 — —
Shantanu NundyChief Medical Officer — — Sep 3, 2026 — —
Frederick John CrawfordDirector — — Aug 4, 2026 0 of 1 —
Paul John SmithDirector — — Aug 4, 2026 — —
Celeste MelletCFO — — May 5, 2026 — —
Michelle A. O'HaraChief Human Resources Officer — — May 5, 2026 — —
James A. RechtinCEO, President — — May 5, 2026 — —
Japan MehtaChief Information Officer — — May 5, 2026 — —
Aaron MartinPresident — — May 5, 2026 — —
Robert Stuart FieldDirector — — May 5, 2026 — —
George Renaudin IIPresident — — Feb 26, 2026 — —
John-Paul W. FelterSvp, Chief Accting Off & Cont. — — Feb 25, 2026 — —
David T. FeinbergDirector — — Jan 5, 2026 — —
Jorge S. MesquitaDirector — — Jan 5, 2026 — —
Gordon SmithDirector — — Nov 4, 2025 — —

Board links: companies that share insiders with HUM

Directors and executives who filed Form 4s for HUM and another company in the last 12 months.

See the map →
  • CMCSAComcast Gordon Smith Director here · Director at CMCSA · latest filing Oct 2, 2026
  • EWEdwards Lifesciences David T. Feinberg Director here · Director at EW · latest filing May 8, 2026
  • MDLZMondelez International Jorge S. Mesquita Director here · Director at MDLZ · latest filing May 21, 2026
  • PODDInsulet Wayne A.I. Frederick Director here · Director at PODD · latest filing Nov 12, 2026
  • TEMTempus AI Wayne A.I. Frederick Director here · Director at TEM · latest filing Nov 12, 2026
  • WDAYWorkday Wayne A.I. Frederick Director here · Director at WDAY · latest filing Nov 12, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

HUM stock: common questions

Are Humana insiders buying HUM stock?

In the past 12 months, 1 insider reported open-market purchases of HUM worth $150K. The latest was President Sanjay K Shetty bought $150K of HUM at $185.21 — first open-market purchase in our records.

Are Humana insiders selling HUM stock?

2 insiders reported sales worth $2.6M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is HUM's P/E ratio?

HUM trades at about 39.8 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is HUM's 52-week range?

Over the past year HUM has traded between $162.46 and $461.25. It last closed at $380.12 on Nov 19, 2026.